These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6965618)

  • 1. Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.
    Davies GC; Sobel M; Salzman EW
    Circulation; 1980 Apr; 61(4):808-14. PubMed ID: 6965618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.
    Watkins WD; Peterson MB; Kong DL; Kono K; Buckley MJ; Levine FH; Philbin DM
    J Thorac Cardiovasc Surg; 1982 Aug; 84(2):250-6. PubMed ID: 6980332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane B2 and fibrinopeptide A levels in platelet consumption and thrombosis.
    Davies GC; Mowschenson PM; Salzman EW
    Surg Forum; 1978; 29():471-2. PubMed ID: 401227
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374).
    Addonizio VP; Fisher CA; Kappa JR; Ellison N
    Surgery; 1987 Nov; 102(5):796-807. PubMed ID: 2445042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma thromboxane and prostacyclin metabolites in sheep partial cardiopulmonary bypass.
    Zapol WM; Peterson MB; Wonders TR; Kong D; Watkins WD
    Trans Am Soc Artif Intern Organs; 1980; 26():556-60. PubMed ID: 7018060
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced plasma thromboxane elevation during partial cardiopulmonary bypass in thrombocytopenic sheep.
    Wonders TR; Southmayd JR; Schuette AH; Huttemeier PC; Kong D; Watkins WD; Carvalho A; Zapol WM
    Trans Am Soc Artif Intern Organs; 1981; 27():276-9. PubMed ID: 7331082
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass.
    Boonstra PW; Gu YJ; Akkerman C; Haan J; Huyzen R; van Oeveren W
    J Thorac Cardiovasc Surg; 1994 Jan; 107(1):289-92. PubMed ID: 8283898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass.
    Chiba Y; Morioka K; Muraoka R; Ihaya A; Kimura T; Uesaka T; Tsuda T; Matsuyama K
    Ann Thorac Surg; 1998 Jan; 65(1):107-13; discussion 113-4. PubMed ID: 9456104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of experimental cardiopulmonary bypass on systemic and transcardiac thromboxane B2 levels.
    Kobinia GS; LaRaia PJ; D'Ambra MN; Fabri BM; Aylesworth CA; Peterson MB; Watkins WD; Buckley MJ
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):852-7. PubMed ID: 3754915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased anticoagulation during cardiopulmonary bypass by aprotinin.
    de Smet AA; Joen MC; van Oeveren W; Roozendaal KJ; Harder MP; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1990 Oct; 100(4):520-7. PubMed ID: 1699088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
    Nakajima H
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay for plasma thromboxane B2.
    McCann DS; Tokarsky J; Sorkin RP
    Clin Chem; 1981 Aug; 27(8):1417-20. PubMed ID: 7273401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of platelet number and haematocrit on whole blood thromboxane synthesis.
    Carter AJ; Hanley SP
    Thromb Haemost; 1985 Apr; 53(2):225-7. PubMed ID: 4024033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
    Tada M; Kuzuya T; Inoue M; Kodama K; Fukushima M; Abe H
    Adv Myocardiol; 1980; 2():397-405. PubMed ID: 7423053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise-induced myocardial ischemia in patients with coronary artery disease: lack of evidence for platelet activation or fibrin formation in peripheral venous blood.
    Marcella JJ; Nichols AB; Johnson LL; Owen J; Reison DS; Kaplan KL; Cannon PJ
    J Am Coll Cardiol; 1983 May; 1(5):1185-93. PubMed ID: 6339591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raised plasma thromboxane B2 levels in alcoholic liver disease.
    Ouwendijk RJ; Zijlstra FJ; Wilson JH; Bonta IL; Vincent JE
    Prostaglandins Leukot Med; 1983 Feb; 10(2):115-22. PubMed ID: 6573682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass.
    Morioka K; Muraoka R; Chiba Y; Ihaya A; Kimura T; Noguti H; Uesaka T
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):45-54. PubMed ID: 8551788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic thrombocytopenic purpura and plasma thromboxane B2 levels.
    Zijlstra FJ; van Vliet HH; Vincent JE
    Thromb Res; 1983 Jun; 30(5):535-8. PubMed ID: 6684333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.